Human Milk Oligosaccharides Market to Account for Robust Growth on account of Surging Health Benefits
The Human Milk Oligosaccharides Market market has witnessed significant growth in recent years owing to growing awareness about its benefits. Human Milk Oligosaccharides Market are complex sugars found in breast milk that support the growth of beneficial microorganisms in the gut of infants. They aid in brain development, modulate immune response and protect against harmful pathogens. The prebiotic nature of HMOs help establish a healthy gut microbiome in newborns. Increasing cases of gastrointestinal disorders and infections in infants have propelled the demand for HMOs as a nutritional supplement.
**The Human Milk Oligosaccharides Market is expected to be valued at USD 298.6 Mn in 2024 , with a market share of USD 50-100 million by 2031 , exhibiting a compound annual growth rate (CAGR) of 14.5% from 2024 to 2031.
Key Takeaways**
Key Players: Major players operating in the Human Milk Oligosaccharides Market market include Inbiose NV, Glycom A/S, Glycosyn LLC, Elicityl SA, Jennewein Biotechnologie GmbH, Medolac Laboratories, and ZuChem Inc.
Growing Demand: Rise in working woman population and growing awareness about benefits of Human Milk Oligosaccharides Market Growth amongst new parents have fuelled the demand. Product innovations with various HMO combinations catering to specific needs is driving market growth.
Technological Advancements: Companies are investing heavily in R&D to develop cost-effective production technologies for large scale manufacturing of HMOs. New techniques involving microbial fermentation have improved yields and lowered costs.
Market Trends
Focus on Clinical Trials: Companies are sponsoring multiple clinical trials to validate therapeutic efficacy of HMOs in treatment of various conditions like necrotizing enterocolitis and certain chronic diseases. Positive trial outcomes will boost commercial adoption.
New Application Areas: Ongoing research explores application of HMOs beyond infant nutrition into gut health supplements, medical foods and clinical therapy. This will expand market opportunities going ahead.
Market Opportunities
Growing Emerging Markets: Emerging economies like China, India, Brazil provide immense opportunities for HMOs market considering rising birth rate and growing health awareness.
Combination Products: Formulation of HMOs with prebiotics, probiotics and vitamins into combination products catering to overall gut and immune health will create new revenue streams.
Impact of Covid-19 on Human Milk Oligosaccharides Market Growth
The outbreak of COVID-19 pandemic has impacted the growth of Human Milk Oligosaccharides Market market globally. During the initial phase of lockdown, production facilities were shut down in many countries which disrupted the supply chain. This adversely affected the market growth. However, with increasing awareness about immunity and nutrition, demand for HMO based infant formulas saw an increase. Many companies ramped up their production to fulfill the rising demand. Gradually, as restrictions were eased, production and supply chain also recovered.
Despite short term challenges, COVID-19 has opened new opportunities for HMO based products. People are more concerned about health and immunity now. As HMOs provide prebiotic benefits and strengthen infant gut and immunity, their demand is expected to rise in the post COVID era. Manufacturers are investing in R&D to develop new formulations containing higher concentration of HMOs. They are also focusing on educational marketing campaigns to increase awareness about benefits of HMOs among new parents. Various clinical studies investigating role of HMOs in reducing risk of viral infections are ongoing. If proven beneficial, it will further boost demand.
Geographical Regions with Highest Revenue Concentration
North America accounts for the largest share of global Human Milk Oligosaccharides Market market in terms of revenue. Advanced technologies enabling large scale production of HMOs and strong presence of leading manufacturers in the US and Canada are major factors driving market growth in the region. Availability of HMO based infant formula products through major retail chains has increased adoption. Growing HMO clinical research in the US is also fuelling market expansion. Europe is another major regional market owing to rising birth rates and expanding pediatric nutrition sector in Germany, France and UK.
Asia Pacific is recognized as the fastest growing regional market for HMOs. Improving economic conditions, increasing awareness about benefits of breastfeeding and rise in working women population are key growth influencers. Countries like China and India with huge population bases present immense business opportunities. Growing private label brands and e-commerce penetration are further expected to accelerate market penetration in Asia Pacific region over coming years.
Get More Insights On- Human Milk Oligosaccharides Market
Get This Report In Japanese Language
Get This Report In Korean Language
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)